Medicament to increase the efficacy of a receptor-mediated triggering apoptosis in tumor cells the drug

The invention relates to a medicament for increasing the efficacy of a receptor-mediated triggering apoptosis in tumor cells medicament, wherein the medicament contains a suitable to inhibit the expression of c-FLIP gene, double-stranded ribonucleic acid (dsRNA).